Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | CNR2 | P34972 | 6/20 | 0.45 |
| ▸ | CNR1 | P21554 | 4/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | PI4KA | P42356 | 1/20 | 0.44 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.44 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.44 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3684239 | 0.83 | CNR1 (0.57) | HSD17B10ALDH1A1HTTCNR2CNR1 | |
| SCHEMBL1078089 | 0.81 | CNR1 (0.56) | HSD17B10ALDH1A1HTTCNR2CNR1 | |
| SCHEMBL5175569 | 0.77 | PI4KA (0.54) | HSD17B10ALDH1A1HTTMAPK1PI4KA | |
| SCHEMBL16063426 | 0.77 | CNR1 (0.54) | HSD17B10ALDH1A1HTTCNR2CNR1 | |
| Adamantane SCHEMBL27759633 | 0.75 | CNR2 (0.70) | HSD17B10ALDH1A1HTTCNR2CNR1 | |
| SCHEMBL23889217 | 0.75 | CNR1 (0.56) | HSD17B10ALDH1A1HTTCNR2CNR1 | |
| SCHEMBL5376005 | 0.74 | ALDH1A1 (0.49) | HSD17B10ALDH1A1HTTMAPK1PI4KA | |
| SCHEMBL27760017 | 0.73 | CNR2 (0.64) | HSD17B10ALDH1A1HTTCNR2CNR1 | |
| Lithium Ion SCHEMBL1078086 | 0.72 | CNR2 (0.56) | HSD17B10HTTCNR2CNR1MAPK1 | |
| SCHEMBL5782959 | 0.71 | MDM2 (0.54) | HSD17B10ALDH1A1HTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240109848-A1 | PROCESS FOR THE PREPARATION OF IMIDAZOBENZODIAZEPINES | ODH IP Corp. (US) | 2024-04-04 | — | — | US | disclosed |
| WO-2024059669-A2 | IMPROVED PROCESS FOR THE PREPARATION OF IMIDAZOBENZODIAZEPINES | ODH IP Corp. (US) | 2024-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240109848-A1 | PROCESS FOR THE PREPARATION OF IMIDAZOBENZODIAZEPINES | CYP3A4, CYP3A5, CYP3A7 | HSD17B10 1498/4885PTGS1 2417/4885PTGS2 2280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.